Birmingham, Alabama 35294


The goal of this proposal is to determine the contribution and significance of obesity to urinary oxalate excretion and thus calcium oxalate kidney stone disease. Successful completion of the study will provide insight into the link between obesity and kidney stone disease and should identify future strategies to treat this disease.


Inclusion Criteria: - Body Mass Index (BMI) < 30 - Calcium oxalate stone formers with passage or removal of a kidney stone containing > 50% calcium oxalate - Type 2 Diabetics with fasting glucose > 126 mg/dL or hemoglobin A1c greater than or equal to 6.5% Exclusion Criteria: - Any disease that will affect the urinary excretion of oxalate, calcium or another ion that will compromise the interpretation of results. - Abnormal urine chemistries or blood metabolic profiles - A glomerular filtration rate (GFR) or estimated GFR < 60 mls/min - Pregnancy - Body Mass Index (BMI) > 32



Primary Contact:

Principal Investigator
Kyle D Wood, MD
University of Alabama at Birmingham

Billy Tingle, RN
Phone: 205-934-3671

Backup Contact:


Location Contact:

Birmingham, Alabama 35294
United States

Billy Tingle, RN
Phone: 205-934-3671

Site Status: Recruiting

Data Source:

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.